These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

210 related items for PubMed ID: 9774198

  • 1. Role of cyclic nucleotide phosphodiesterases in ischemic preconditioning.
    Lochner A, Genade S, Tromp E, Opie L, Moolman J, Thomas S, Podzuweit T.
    Mol Cell Biochem; 1998 Sep; 186(1-2):169-75. PubMed ID: 9774198
    [Abstract] [Full Text] [Related]

  • 2. Role of cyclic AMP- and cyclic GMP-phosphodiesterases in the control of cyclic nucleotide levels and smooth muscle tone in rat isolated aorta. A study with selective inhibitors.
    Schoeffter P, Lugnier C, Demesy-Waeldele F, Stoclet JC.
    Biochem Pharmacol; 1987 Nov 15; 36(22):3965-72. PubMed ID: 2825708
    [Abstract] [Full Text] [Related]

  • 3. Ischemic preconditioning and the beta-adrenergic signal transduction pathway.
    Lochner A, Genade S, Tromp E, Podzuweit T, Moolman JA.
    Circulation; 1999 Aug 31; 100(9):958-66. PubMed ID: 10468527
    [Abstract] [Full Text] [Related]

  • 4. A comparison between ischemic preconditioning and anti-adrenergic interventions: cAMP, energy metabolism and functional recovery.
    Moolman JA, Genade S, Tromp E, Lochner A.
    Basic Res Cardiol; 1996 Aug 31; 91(3):219-33. PubMed ID: 8831941
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Profiling of cAMP and cGMP phosphodiesterases in isolated ventricular cardiomyocytes from human hearts: comparison with rat and guinea pig.
    Johnson WB, Katugampola S, Able S, Napier C, Harding SE.
    Life Sci; 2012 Feb 27; 90(9-10):328-36. PubMed ID: 22261303
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Angiotensin-converting enzyme inhibition prevents myocardial infarction-induced increase in renal cortical cGMP and cAMP phosphodiesterase activities.
    Clauss F, Charloux A, Piquard F, Doutreleau S, Talha S, Zoll J, Lugnier C, Geny B.
    Fundam Clin Pharmacol; 2015 Aug 27; 29(4):352-61. PubMed ID: 25939307
    [Abstract] [Full Text] [Related]

  • 11. "cAMP-specific" phosphodiesterase contributes to cGMP degradation in cerebellar cells exposed to nitric oxide.
    Bellamy TC, Garthwaite J.
    Mol Pharmacol; 2001 Jan 27; 59(1):54-61. PubMed ID: 11125024
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Absence of an effect of the lithium-induced increase in cyclic GMP on the cyclic GMP-stimulated phosphodiesterase (PDE II). Evidence for cyclic AMP-specific hydrolysis.
    Harvey B, Carstens M, Taljaard J.
    Neurochem Res; 1993 Oct 27; 18(10):1095-100. PubMed ID: 8255358
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. No evidence for mediation of ischemic preconditioning by alpha 1-adrenergic signal transduction pathway or protein kinase C in the isolated rat heart.
    Moolman JA, Genade S, Tromp E, Lochner A.
    Cardiovasc Drugs Ther; 1996 May 27; 10(2):125-36. PubMed ID: 8842504
    [Abstract] [Full Text] [Related]

  • 20. Cyclic 3',5'-adenosine monophosphate phosphodiesterase (cAMP PDE) and cyclic 3',5'-guanosine monophosphate phosphodiesterase (cGMP PDE) in microvessels isolated from bovine cortex.
    Stefanovich V.
    Neurochem Res; 1979 Dec 27; 4(6):681-7. PubMed ID: 232543
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.